600285 Henan Lingrui Pharmaceutical
- 24.58
- +0.87+3.67%
Henan Lingrui Pharmaceutical News
Announcement of the Resolution of the Ninth Supervisory Board of the Seventh Meeting of Henan Lingrui Pharmaceutical
Announcement of the resolutions of the eighth meeting of the ninth board of directors of Henan Lingrui Pharmaceutical.
Special legal opinion on the completion of the assessment indicators for the third unlocking period of Henan Lingrui Pharmaceutical Co., Ltd.'s 2021 employee stock ownership plan.
Legal Opinion on the Differentiated Dividend of Henan Lingrui Pharmaceutical Co., Ltd.
Henan Ling Rui Pharmaceutical Co., Ltd. Independent Director Working System
Rules of procedure for the shareholders' meeting of Henan Lingrui Pharmaceutical Co., Ltd.
Rules of procedure for the board of supervisors of Henan Ling Rui Pharmaceutical Co., Ltd.
Articles of Association of Henan Ling Rui Pharmaceutical Co., Ltd. (2024.5)
Announcement of Ling Rui Pharmaceutical on obtaining a drug registration certificate
Announcement of Ling Rui Pharmaceutical on holding the 2023 Annual Results Briefing
Ling Rui Pharmaceutical's 2023 Social Responsibility Report
2023 Independent Director Debriefing Report (Yang Jun)
2023 Independent Director Debriefing Report (Mei Xiaying)
Ling Rui Pharmaceutical Internal Control Audit Report
Special instructions on the use of capital by controlling shareholders and other related parties
Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Ling Rui Pharmaceutical
Ling Rui Pharmaceutical's 2023 Accounting Firm Performance Assessment Report
Special opinion of the board of directors of Lingrui Pharmaceutical on the 2023 independence assessment of independent directors
Announcement of Ling Rui Pharmaceutical on changes in accounting policies
Ling Rui Pharmaceutical 2023 Audit Report
Analysis
Price Target
No Data
